Back to search

Netherlands· NL-5338b4335715

Custodiol, oplossing voor cardioplegie

A kardioplegie lösungen product containing calciumchloride 2-water (e 509) + histidine, (l-) + histidinemonohydrochloride 1-water (l-) + kalium watersof-2-oxoglutaraat, registered in Netherlands by Dr. Franz Kohler Chemie GmbH. The same ATC class is registered in 7 of our 19 countries.

ATC B05XA16

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCustodiol, oplossing voor cardioplegieATCB05XA16REGISTER NO.NL-5338b4335715PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Kardioplegie lösungen is registered in 7 of 19 countries.

Countries holding a registration under ATC B05XA16 (kardioplegie lösungen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose

Kardioplegie lösungen · ATC B05XA16

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CALCIUMCHLORIDE 2-WATER (E 509) + HISTIDINE, (L-) + HISTIDINEMONOHYDROCHLORIDE 1-WATER (L-) + KALIUM WATERSOF-2-OXOGLUTARAAT
Manufacturer
Dr. Franz Kohler Chemie GmbH
Country
Netherlands (NL)
ATC code
B05XA16
ATC class
Kardioplegie Lösungen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    12801

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d635b9dc-80c6-449d-8ca8-3da03de55e12
GET /v1/drugs/d635b9dc-80c6-449d-8ca8-3da03de55e12?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor cardioplegie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h12801_smpc.pdf",
  "strength": null,
  "atc_label": "Cardioplegia Solutions",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg12801",
  "excipients": [
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "CALCIUMCHLORIDE 2-WATER (E 509)",
    "HISTIDINE, (L-)",
    "HISTIDINEMONOHYDROCHLORIDE 1-WATER (L-)",
    "KALIUM WATERSOF-2-OXOGLUTARAAT",
    "KALIUMCHLORIDE (E 508)",
    "MAGNESIUMCHLORIDE 1,5-WATER (E 511)",
    "MANNITOL (D-) (E 421)",
    "NATRIUMCHLORIDE",
    "TRYPTOFAAN, (L-)"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h12801.pdf",
  "authorised_at": "1989/11/13",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "12801",
  "additional_monitoring": "N"
}

See everything about kardioplegie lösungen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.